{Reference Type}: Letter
{Title}: PASH syndrome: A novel MEFV mutation variant with excellent response to adalimumab in a refractory case.
{Author}: Feola H;Luna Cian R;Mancinelli MC;Cordoba LM;Crespi C;
{Journal}: Int J Dermatol
{Volume}: 0
{Issue}: 0
{Year}: 2024 Jun 16
{Factor}: 3.204
{DOI}: 10.1111/ijd.17330